ATXN2 has been reported to be overexpressed in pancreatic adenocarcinoma (PAAD) tumor tissues, and overexpression of ATXN2 promotes PADD cell proliferation, migration, and invasion (Fang et al., 2021). The gene discussed is ATXN2; the disease is neoplasm.